Search Results - Mingjun Rui

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Health Economic Evaluations of Circulating Tumor DNA Testing for Cancer Screening: Systematic Review by Mingjun Rui, Yingcheng Wang, Joyce H. S. You

    Published in Cancer Medicine (2025-02-01)
    Get full text
    Article


  2. 2

    HRR deficiency-guided use of talazoparib plus enzalutamide in patients with metastatic castration-resistant prostate cancer: a cost-effectiveness analysis by Mingjun Rui, Yingcheng Wang, Qiran Wei, Joyce H. S. You

    Published in Therapeutic Advances in Medical Oncology (2025-07-01)
    Get full text
    Article


  3. 3

    Cost-effectiveness of combining AI and cfDNA with LDCT for lung cancer screening in China: a modelling study by Mingjun Rui, Yingcheng Wang, Zhengwei Huang, Yunfei Li, Hongchao Li

    Get full text
    Article


  4. 4

    Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US by Yingcheng Wang, Yingcheng Wang, Mingjun Rui, Mingjun Rui, Lan Yang, Lan Yang, Xintian Wang, Xintian Wang, Ye Shang, Ye Shang, Aixia Ma, Aixia Ma, Hongchao Li, Hongchao Li

    Published in Frontiers in Public Health (2021-04-01)
    Get full text
    Article


  5. 5

    Economic evaluation of sintilimab plus chemotherapy vs. pembrolizumab plus chemotherapy for the treatment of first-line advanced or metastatic squamous NSCLC by Pingyu Chen, Pingyu Chen, Xintian Wang, Shengwen Zhu, Hongchao Li, Hongchao Li, Mingjun Rui, Yingcheng Wang, Haikui Sun, Aixia Ma, Aixia Ma

    Published in Frontiers in Public Health (2022-08-01)
    Get full text
    Article


Search Tools: